Top Midday Decliners

MT Newswires Live

1 hour ago

Concentrix (CNXC) reported a decline in fiscal Q1 adjusted earnings Tuesday, which, along with its fiscal Q2 adjusted earnings per share forecast, missed analysts' estimates.

Shares slid nearly 24% as midday trading volume jumped to over 5.4 million shares from a daily average of about 1.3 million.

ImmunityBio (IBRX) shares dropped roughly 22% after the US Food and Drug Administration issued a warning letter citing "misleading" promotional materials for its bladder cancer drug Anktiva.

Trading volume stood at over 71.9 million shares, versus a daily average of roughly 37.3 million.

Lenz Therapeutics (LENZ) reported a Q4 net loss of $1.16 per diluted share, widening from a loss of $0.46 per share a year earlier.

Shares fell about 18%, with trading volume of 2.8 million shares against a daily average of about 954,000.

Price: 25.12, Change: -7.92, Percent Change: -23.97

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2622609723"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2622609723\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2622609723?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-25 02:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622609723","market":"sg","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> Concentrix (CNXC) reported a decline in fiscal Q1 adjusted earnings Tuesday, which, along with its fiscal Q2 adjusted earnings per share forecast, missed analysts' estimates.</p><p>Shares slid nearly 24% as midday trading volume jumped to over 5.4 million shares from a daily average of about 1.3 million.</p><p>ImmunityBio (IBRX) shares dropped roughly 22% after the US Food and Drug Administration issued a warning letter citing \"misleading\" promotional materials for its bladder cancer drug Anktiva.</p><p>Trading volume stood at over 71.9 million shares, versus a daily average of roughly 37.3 million.</p><p>Lenz <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (LENZ) reported a Q4 net loss of $1.16 per diluted share, widening from a loss of $0.46 per share a year earlier.</p><p>Shares fell about 18%, with trading volume of 2.8 million shares against a daily average of about 954,000.</p><p>Price: 25.12, Change: -7.92, Percent Change: -23.97</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-25 02:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Concentrix (CNXC) reported a decline in fiscal Q1 adjusted earnings Tuesday, which, along with its fiscal Q2 adjusted earnings per share forecast, missed analysts' estimates.</p><p>Shares slid nearly 24% as midday trading volume jumped to over 5.4 million shares from a daily average of about 1.3 million.</p><p>ImmunityBio (IBRX) shares dropped roughly 22% after the US Food and Drug Administration issued a warning letter citing \"misleading\" promotional materials for its bladder cancer drug Anktiva.</p><p>Trading volume stood at over 71.9 million shares, versus a daily average of roughly 37.3 million.</p><p>Lenz <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (LENZ) reported a Q4 net loss of $1.16 per diluted share, widening from a loss of $0.46 per share a year earlier.</p><p>Shares fell about 18%, with trading volume of 2.8 million shares against a daily average of about 954,000.</p><p>Price: 25.12, Change: -7.92, Percent Change: -23.97</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4226","symbol_name":"数据处理及外包服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2622609723","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622609723","pubTimestamp":1774377458,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Concentrix (CNXC) reported a decline in fiscal Q1 adjusted earnings Tuesday, which, along with its fiscal Q2 adjusted earnings per share forecast, missed analysts' estimates.Shares slid nearly 24% as ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4226":"数据处理及外包服务","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","BK4007":"制药","CNXC":"Concentrix Corp","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","BK4539":"次新股","IBRX":"ImmunityBio, Inc.","LENZ":"Therapeutics","BK4139":"生物科技","BK4106":"数据处理与外包服务","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC"},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNXC":1,"IBRX":1,"LENZ":1},"content_text":"Concentrix (CNXC) reported a decline in fiscal Q1 adjusted earnings Tuesday, which, along with its fiscal Q2 adjusted earnings per share forecast, missed analysts' estimates.Shares slid nearly 24% as midday trading volume jumped to over 5.4 million shares from a daily average of about 1.3 million.ImmunityBio (IBRX) shares dropped roughly 22% after the US Food and Drug Administration issued a warning letter citing \"misleading\" promotional materials for its bladder cancer drug Anktiva.Trading volume stood at over 71.9 million shares, versus a daily average of roughly 37.3 million.Lenz Therapeutics (LENZ) reported a Q4 net loss of $1.16 per diluted share, widening from a loss of $0.46 per share a year earlier.Shares fell about 18%, with trading volume of 2.8 million shares against a daily average of about 954,000.Price: 25.12, Change: -7.92, Percent Change: -23.97","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}